SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000929638-22-000419
Filing Date
2022-02-11
Accepted
2022-02-11 17:01:32
Documents
1
Group Members
JEFF EASTONLIND GLOBAL PARTNERS LLC

Document Format Files

Seq Description Document Type Size
1 sc13g.htm SC 13G/A 67167
  Complete submission text file 0000929638-22-000419.txt   68837
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Subject) CIK: 0001610820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: SC 13G/A | Act: 34 | File No.: 005-92289 | Film No.: 22622415
SIC: 2834 Pharmaceutical Preparations

Mailing Address 444 MADISON AVE, FLOOR 41 NEW YORK NY 10022
Business Address 444 MADISON AVE, FLOOR 41 NEW YORK NY 10022 646-395-3931
Lind Global Macro Fund LP (Filed by) CIK: 0001773156 (see all company filings)

IRS No.: 830854952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A